Chapter 1. Introduction to Negotiating Mergers and Acquisitions
Pfizer, the pharmaceutical industry behemoth, was growing increasingly uneasy in early 2008. It had few blockbuster drugs in the pipeline, and several of its major revenue-generating drugs were about to lose patent protection. Pfizer had made several major acquisitions earlier in the decade and now looked to acquire another drug company to offset potential revenue losses. CEO Jeffrey Kindler placed a call to Wyeth Pharmaceutical's chief executive that spring.
Pfizer, the pharmaceutical industry behemoth, was growing increasingly uneasy in early 2008. It had few blockbuster drugs in the pipeline, and several of its major revenue-generating drugs were about to lose patent protection. ...
Get Mergers and Acquisitions Basics now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
